Land: Israel
Språk: engelska
Källa: Ministry of Health
DIPYRIDAMOLE
RAFA LABORATORIES LTD
B01AC07
TABLETS
DIPYRIDAMOLE 75 MG
PER OS
Required
RAFA LABORATORIES LTD, JERUSALEM
DIPYRIDAMOLE
DIPYRIDAMOLE
As an adjunct to oral anticoagulants for prophylaxis of thromboembolism associated with prosthetic heart valves. Reduction of proteinuria in the nephrotis syndrome. Treatment of membranoproliferative glomerulonephritis. Prevention of pre-eclampsia in the final trimester of pregnancy. Prevention of transplant artery stenosis. Prevention of post-operative thromboembolic complications of coronary artery surgery. In combination with acetylsalicylic acid in cases of recurrent deep vein thrombosis resistant to oral anticoagulants. Prevention of thrombogenic manifestations. As an alternative to exercise stress in thallium myocardial imaging particularly in patients unable to exercise or in those for whom exercise may be contraindicated.
2012-06-30
רישכתה םש הטרופ ןיסכודראק אפר ט"קמ 194012 הרודהמ 'סמ 012004- I הסירפ )2( 'ג / 3 חפסנ יפל מ"ס 16X25 עבצ רוחש תופש )תיברעו תילגנא ,תירבע( 3 סופד לאידיא םילופיק 'סמ 0 :לופיק רחאל יפוס לדוג מ"מ 24.5X16 ריינ גוס םרג 60 דוקהמרפ )תולע אלל דוקמרפה תא שיבלי סופדה תיב( 637 דוקהמרפ יוקל תודימ ;מ"מ 1 םיווקה ןיב חוור ;מ"מ 1.5 הבע וק ;מ"מ 0.5 קד וק תופידע - מ"מ 8 םומינימ( מ"מ 10 םומיסקמ וטנ ךרוא )תילמיסקמ הדימל י"ע ןכוה םייטבצמרפ םיתוריש ואלב ךיראת 21.06.2012 :ةعرلجا .عضرلاو لافطلأل ماع لكشب صصمخ يرغ ءاودلا اذه .اهب ىصولما ةعرلجا زواتج زويج لا .طقف بيبطلا تاميلعتل ا ً قفو ةعرلجا بيبطلا لبق نم د ّ دح ام بسبح ةددمح تاقوأب ءاودلا اذه لامعتسا بيج .لجاعلما .كركذت روف ةعرج لوانت بيج ددلمحا تقولا في ءاودلا اذه لوانت تيسن اذإ ا ً عطق زويج لا .ةيسنلما ةعرلجا ىطتخ ,ةيلاتلا ةعرلجا لوانتل تقولا ناح اذإ !اعم ينتعرج لوانت :لامعتسلاا ةيفيك .ءام سأك عم ءاودلا علب بيج !صرقلا قحس وأ غضم زويج لا .ةبجولا لبق ءاودلا لوانتب ىصوي .هعلبل ةمزللا ة ّ د ُ لما نم رثكأ مفلا في ءاودلا ءاقبإ زويج لا .فيصنت طخ دوجو مدعل كلذو صرقلا رطش زويج لا ؟جلاعلا حاجنب ةمهاسلما كنكيم فيك .بيبطلا لبق نم هب ىصولما جلعلا لامكإ كيلع نستح أرط ولو تىح بيبطلا ةراشتسا نودب ءاودلاب جلعلا نع فقوتت لا .ةيحصلا كتلاح ىلع !ممستلا بنتج يديأ Läs hela dokumentet
CARDOXIN FORTE-DL-June 2012-02 DOCTOR LEAFLET CARDOXIN FORTE TABLETS COMPOSITION Active ingredient: each tablet contains: dipyridamole 75 mg Inactive ingredients: Starch corn, silicon dioxide colloidal 200, starch soluble, magnesium stearate, calcium phosphate dibasic anhydrous, lactose monohydrate, hydroxypropylmethylcellulose, titanium dioxide, macrogol 4000, sunset yellow 85 (E110). Each tablet contains approx. 2 mg lactose. ACTION Dipyridamole increases coronary blood flow and coronary sinus oxygen saturation. It appears to act predominantly on the small resistance vessels of the coronary vascular bed. The coronary vasodilator effect of dipyridamole is probably due to its ability to inhibit adenosine deaminase in the blood, thus allowing the accumulation of adenosine, a potent vasodilator. It may also cause vasodilation by inhibiting the enzyme phosphodiesterase, thus delaying the hydrolysis of cyclic adenosine monophosphate (cAMP). In vitro models, induced-thrombotic animal models and several clinical studies have shown that the prophylactic administration of the proper dose of dipyridamole can, in many cases, reduce the number of thromboembolic episodes. This is based on its ability to prevent platelet adhesion and aggregation, thus prolonging platelet survival time. It is postulated that dipyridamole acts by enhancing prostacyclin effects or inhibiting phosphodiesterase, thus increasing adenyl cyclase formation. It has also been shown to inhibit the formation of thromboxane-A 2 , which is known to cause platelet adhesion and aggregation. INDICATIONS As an adjunct to oral anticoagulants for prophylaxis of thromboembolism associated with prosthetic heart valves. Reduction of proteinuria in the nephrotic syndrome. Treatment of membranoproliferative glomerulonephritis. Prevention of pre-eclampsia in the final trimester of pregnancy. Prevention of transplant artery stenosis. Prevention of post-operative thromboembolic complications of coronary artery surgery. In combination with acetylsalicylic acid in cases of Läs hela dokumentet